Sponsor pipeline

Shanghai Chest Hospital clinical trial pipeline

Get alerts when Shanghai Chest Hospital's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-09-21 NCT07830095 5G-Enabled Remote Robotic-Assisted Bronchoscopy-Guided Cryoablation for Pulmonary… Not Yet Recruiting
2026-09-21 NCT07830355 Immunotherapy Plus Anlotinib After Surgery for Esophageal Squamous Cell Cancer With… Phase 2 Not Yet Recruiting

Active trials by phase

Phase 1
1
Phase 1/2
5
Phase 2
26
Phase 2/3
2
Phase 3
2
Phase 4
1
Not charted: 57 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials

Lung Cancer (54) · Non-Small Cell Lung Cancer (NSCLC) (32) · Esophageal Cancer (12) · Heart Disease (12) · Atrial Fibrillation (9) · Small Cell Lung Cancer (4) · COPD (1) · Heart Failure (1)

Get alerts when Shanghai Chest Hospital's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free